Radiation Therapy clinical trials

Explore recruiting radiation therapy clinical trials.

Recruiting radiation therapy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Radiation Therapy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II, open label, single arm, multicentre study on THOracic Radiotherapy in Extensive Stage SCLC patients submitted to first line CHT-RT plus Durvalumab (MEDI4736)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase I-II prospective trial, multicenter, open label, exploring the combination of Trabectedin plus RAdiotherapy in Soft Tissue Sarcoma patients

Italy, Spain, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

PEACE 8: Combination of darolutamide and stereotactic body radiation therapy in patients with castration resistant prostate cancer and oligometastases on functional imaging.

France, Belgium, Ireland, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Single-arm dose-escalation Phase 1/2 study of olaptesed pegol (NOX-A12) in combination with irradiation in inoperable or partially resected first-line glioblastoma patients with unmethylated MGMT promoter with a multiple-arm expansion group

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Hormonal Receptor (HR)-positive HER2 negative breast cancer patients treated with preoperative ELacestrant and PULSAR adaptive radiotherapy: a phase II study

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase I/II multicenter trial evaluating the association of hypofractionated stereotactic radiation therapy and the anti-PD-L1 Durvalumab (Medi4736) for patients with recurrent glioblastoma

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Radiation Therapy trials by city

Radiation Therapy in Toronto Radiation Therapy in Vancouver Radiation Therapy in Montreal Radiation Therapy in Calgary Radiation Therapy in Edmonton Radiation Therapy in Ottawa Radiation Therapy in Winnipeg Radiation Therapy in Quebec City Radiation Therapy in Hamilton Radiation Therapy in Kitchener Radiation Therapy in London Radiation Therapy in Halifax Radiation Therapy in New York Radiation Therapy in Los Angeles Radiation Therapy in Chicago Radiation Therapy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease